ArticleJournal of medical biochemistry2025
Impact of goal-directed fluid therapy on serum cytokines (IL-2, IFN-g, TNF-a, IL-6, IL-8, and IL-10) in elderly patients undergoing thoracotomy.
Article in Journal of medical biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This research aimed to investigate the effect of different fluid therapy approaches (conventional and goal-directed fluid management) on TH1 and TH 2 cytokines (IL-2, IFN-g, TN F-a, IL-6, and IL-8, IL-10) during the perioperative period of thoracotomy in elderly patients; as previous studies have only focused on surgical outcomes of goal-directed fluid management. Methods: Sixty elderly patients who underwent thoracotomy from January 2022 to April 2024 were divided into the control group (CG) and the observation group (OG), with 30 cases in each group. The CG received routine fluid management, while the OG received goal-directed fluid management. The postoperative recovery status, fluid intake and output, hemodynamic indexes, and TH1 and TH 2 cytokine levels were compared between both groups. Results: The postoperative extubation time, drainage time, ICU stay and hospitalisation time in the OG were reduced than those in the CG (P<0.05). The urine volume, crystalloid volume, colloid volume and total fluid volume in the OG were reduced than in the CG (P<0.05). At 1 h after surgery (T2), the HR and MAP levels of the two groups were reduced than those before surgery (T1) (P<0.05); at the end of surgery (T3), the HR and MAP of the CG were raised than those at T1 (P<0.05); at T2, the HR and MAP levels in the OG were raised than those in the CG (P<0.05); at T3, the HR and MAP levels in the OG were reduced than those in the CG (P<0.05). 1 day after operation, the levels of IL-2, IFN-g, TN F-a, IL-6, and IL-8 were raised than those before surgery, (P< 0.05), and the levels of IL-10 was reduced than those before treatment (P<0.05). Conclusions: Perioperative goal-directed fluid therapy for elderly patients with thoracotomy is beneficial to maintaining perioperative hemodynamic stability, improving serum levels of TH1 and TH 2 cytokines, reducing the body's inflammatory response, and facilitating early postoperative recovery. This was a novel finding that needs further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.